The human vasopressin V2 receptor belongs to the large family of G-protein-coupled receptors, which possess seven transmembrane helices, an extracellular N terminus and an intracellular C terminus. We have determined the sequence requirements of the V2 receptor for membrane insertion and correct topology for the inner membrane of Escherichia coli with the PhoA/LacZ gene fusion system. In addition, we have studied the signals for its membrane insertion and correct topology for the membrane of the endoplasmic reticulum of the authentic eucaryotic transport system. To this end, we have extended the PhoA/LacZ gene fusion system for the first time to eucaryotic cells, i.e. transiently transfected COS.M6 cells. Truncated V2 receptor sequences were fused to PhoA and LacZ and expressed in both E. coli and COS.M6 cells. Cells were fractionated, and LacZ/ PhoA activity assays and immunoblots were performed. We show here that a V2 receptor fragment consisting of the N terminus, the first transmembrane segment and the first cytoplasmic loop (71 amino acids) provided sufficient information for membrane insertion and correct orientation (extracellular N terminus) in both procaryotic and eucaryotic cells. Our data differ substantially from those obtained for the human ␤ 2 -adrenergic receptor expressed in E. coli (Lacatena, R. M., Cellini, A., Scavizzi, F., and Tocchini-Valentini, G. P. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 10521-10525). To establish correct topology, the ␤ 2 -adrenergic receptor requires a larger receptor portion, including the three N-terminal transmembrane segments and/or parts of the second cytoplasmic loop. The present data show that the observations made for the ␤ 2 -adrenergic receptor cannot be applied to G-protein-coupled receptors generally.
The average hydrophobicity of the primary sequence of a membrane protein can be used to predict its transmembrane organization. Based on hydrophobicity analysis, the vasopressin V2 receptor belongs to the large family of GPCRs 1 with seven transmembrane helices (1, 2) . According to the predicted topology, the V2 receptor can be classified as a multi-spanning type I membrane protein (3, 4) , which lacks a cleavable signal sequence and has an extracellular N terminus and a cytoplasmic C terminus.
Although the mechanisms of ER-membrane insertion and translocation of multi-spanning type I proteins have not been studied in detail, it is thought that the first transmembrane helix serves as an internal signal sequence for membrane targeting and insertion (4, 5) . The hydrophilic N terminus preceding the signal sequence is believed to be devoid of rapidly folding elements, since it must be translocated across the membrane before insertion of the signal sequence (6) . Positively charged residues adjacent to the signal anchor sequence in the first cytoplasmic loop were proposed to determine the orientation of the first transmembrane helix, and consequently the topology of the whole protein (7) (8) (9) .
Various in vivo strategies have been developed to study the sequence determinants for the establishment of membrane protein topology. In eucaryotic cells, predominantly external domains have been assessed with monoclonal antibodies, proteases and artificial glycosylation sites. For the inner membrane of Escherichia coli, gene fusion systems have been developed to determine the transmembrane organization of proteins. Topological information was gained by the fusion of PhoA (10) and LacZ (11) to the putative internal and external domains followed by activity assays for the enzyme portions: PhoA is only active after transport across the inner membrane, whereas LacZ loses activity if the cells attempt to export the enzyme. Thus two complementary fusions to one domain can be used as "sensors" of its localization (11) .
Many data suggest that the protein translocation machineries of the inner membrane of E. coli and of the eucaryotic ER membrane are related (12) . In addition, previous studies revealed that GPCRs can be expressed functionally in membrane fractions of E. coli (13) . Therefore, it appeared reasonable to study the signals for transmembrane organization of GPCRs in E. coli with the fusion protein systems described above. Expression of truncated human ␤ 2 -adrenergic receptor fused to bacterial PhoA in E. coli proved that the first transmembrane helix alone is sufficient for membrane targeting and insertion. However, additional sequences of the third transmembrane helix and/or the second cytoplasmic loop were found to be necessary to establish its correct orientation (14) . Similarly, the first transmembrane helix of the cyclic nucleotide-gated ion channel from bovine rod photoreceptor failed to establish correct orientation of a PhoA fusion protein (15) . It is not clear whether these conclusions hold true for the authentic transport system of the ER membrane of eucaryotic cells.
In the present study we have compared the sequence requirements of the human V2 receptor for membrane insertion and correct topology for the inner membrane of E. coli with those for the authentic transport system of the ER membrane of eucaryotic COS.M6 cells. Fusions of truncated V2 receptor sequences to bacterial PhoA and LacZ were expressed in both cell systems. After cell fractionation, LacZ and PhoA activity assays and immunoblots were used to determine the localization and orientation of the fusion proteins. We show here, that in contrast to the ␤ 2 -adrenergic receptor, a V2 receptor fragment consisting of the N terminus, first transmembrane helix, and first intracellular loop is sufficient to establish correct topology not only in E. coli but also in COS.M6 cells.
EXPERIMENTAL PROCEDURES
Materials-Lipofectin was obtained from Life Technologies, Inc. (Eggenstein, Germany). SrfI was from Stratagene (Heidelberg, Germany); all other enzymes were from New England Biolabs (Schwalbach, Germany). Nonoethyleneglycol octylphenyl ether (Nonidet P-40) was from Calbiochem (Bad Soden, Germany). Ampicillin, aprotinin, benzamidine, isopropyl-1-thio-␤-D-galactopyranoside (IPTG), phenylmethylsulfonyl fluoride (PMSF), o-nitrophenyl-␤-D-galactopyranoside (ONPG), p-nitrophenyl phosphate (PNPP), and trypsin inhibitor were from Sigma (Mü nchen, Germany). All other reagents were from Merck (Darmstadt, Germany). The polyclonal rabbit anti-PhoA antibody has been described (16); anti-rabbit 125 I-IgG (28 -111 TBq/mmol) was from Amersham (Braunschweig, Germany). The V2 receptor expression plasmid pRCDN2 has been described (20) . The procaryotic expression vector pTRC99A and the LacZ encoding plasmid pCH110 were from Pharmacia (Freiburg, Germany). PhoA and LacZ genes were derived from fusions to E. coli hlyD (17) . The PhoA/LacZ-negative E. coli strain CC118 has been described (10); African green monkey kidney (COS.M6) cells were from F. Fahrenholz (Max-Planck-Institut fü r Biophysik, Frankfurt, Germany), Ltk Ϫ mouse fibroblasts were from M. Birnbaumer (UCLA School of Medicine, Los Angeles, CA).
DNA Manipulations-Standard DNA preparations and manipulations were carried out according to the handbooks of Sambrook et al. (17) and Perbal (18 (20) .
Growth Conditions and Cell Fractionation of E. coli CC118 -E. coli CC118 was cultivated in dYT medium (16 g/liter bactopeptone, 10 g/liter yeast extract, 5 g/liter NaCl) or on dYT agar plates at 37°C. Ampicillin was used at a final concentration of 50 g/ml. The method used for cell fractionation is based on the work of Koshland and Botstein (21) . 50 ml of dYT medium supplemented with 50 g/ml ampicillin were inoculated with a 1-ml overnight culture of an E. coli CC118 clone and grown at 37°C for 3.5 h with aeration. Cells were induced with IPTG (1 mM final concentration) and grown for 1 h at 37°C with aeration. Bacteria were harvested (10 min, 8,000 ϫ g, 4°C) and resuspended in 2.25 ml of ice-cold osmotic shock buffer (100 mM Tris-HCl, 0.5 mM EDTA, 500 mM sucrose, pH 8.0) supplemented with 0.5 mM PMSF, 0.5 mM benzamidine, 3.2 g/ml trypsin inhibitor, and 1.4 g/ml aprotinin. After addition of 250 l of lysozyme solution (1 mg/ml shock buffer) and 2.25 ml of ice-cold H 2 O, cells were incubated for 1 h on ice to allow the formation of spheroplasts. The spheroplast suspension was supplemented with 200 l of MgCl 2 (500 mM) and centrifuged at 10,000 ϫ g for 10 min at 4°C. The supernatant containing the periplasmic fraction (5 ml) was removed and cells were resuspended in 5 ml of lysis buffer (10 mM Tris-HCl, pH 8.0, 0.5 mM PMSF, 0.5 mM benzamidine, 3.2 g/ml trypsin inhibitor, and 1.4 g/ml aprotinin). Cell lysis was completed by sonification (5 ϫ 3 s), and the lysate was centrifuged at 150,000 ϫ g. The supernatant (5 ml) containing the cytoplasmic fraction was removed, and the membrane pellet was washed twice with 5 ml of lysis buffer and finally resuspended in 0.5 ml of lysis buffer. Cytoplasmic and periplasmic fractions were precipitated for 30 min at 4°C with one volume of 90% acetone, 50 mM NaCl and finally resuspended in 0.5 ml of lysis buffer.
PhoA and LacZ Activity Assays for E. coli CC118 Clones-The PhoA and LacZ activity assays are based on the protocols of Brickman and Beckwith (22) and Miller (23) , respectively. The assays were carried out with 50 l of membranes, 50 l of cytoplasm, and 50 l of periplasm obtained from the fractionation procedure described above (each sample corresponding to 2.8 ϫ 10 9 cells). To determine PhoA activity, each sample was supplemented with 850 l of 1 M Tris-HCl, pH 8.0, 50 l of chloroform, and 50 l of 0.1% SDS. Reactions were started by the addition of 100 l of PNPP solution (5 mg/ml in 1 M Tris-HCl, pH 8.0), incubated for 30 min at 28°C, and stopped with 100 l of 1 M KH 2 PO 4 ; A 420 was measured after brief centrifugation (separation of organic and aqueous phases).
To determine LacZ activity, samples were supplemented with 850 l of Z buffer (60 mM Na 2 HPO 4 , 40 mM NaH 2 PO 4 , 10 mM KCl, 1 mM MgCl 2 , 50 mM ␤-mercaptoethanol), 50 l of chloroform, and 50 l of 0.1% SDS. Reactions were started by the addition of 200 l of ONPG solution (4 mg/ml in 100 mM K 2 HPO 4 , pH 7.0), incubated for 15 min at 28°C, and stopped with 500 l of 1 M Na 2 CO 3 ; A 420 was measured after centrifugation.
Fractionation of COS.M6 Cells-The fractionation procedure was carried out with confluent COS.M6 cells from one 60-mm diameter dish. To isolate the extracellular fraction, medium was removed and the proteins were precipitated 30 min at 4°C with one volume of 90% acetone, 50 mM NaCl and resuspended in 500 l of PBSI (8 g/liter NaCl, 0.2 g/liter KCl, 0.2 g/liter KH 2 PO 4 , 1.44 g/liter Na 2 HPO 4 , 0.5 mM PMSF, 0.5 mM benzamidine, 3.2 g/ml trypsin inhibitor, 1.4 g/ml aprotinin). To isolate membrane-bound and cytoplasmic fractions, cells were washed twice with PBS (PBSI without protease inhibitors) and scraped into 500 l of PBSI. For lysis, cells were sonicated on ice (2 ϫ 2 s); intact cells and larger debris were removed by brief centrifugation at 250 ϫ g. The supernatant was centrifuged at 150,000 ϫ g for 1 h at 4°C to separate membranes and cytoplasm. The 500-l cytoplasmic supernatant was removed and the membrane pellet was washed with 1 ml of PBSI. The resulting suspension was recentrifuged as described above and resuspended in 500 l of PBSI.
PhoA and LacZ Activity Assays for COS.M6 Cells-For COS.M6 cells, the fractionation procedure yielded 500 l of extracellular proteins, 500 l of cytoplasm, and 500 l of membranes from a 60-mm diameter dish (see above).
To determine PhoA activity, each sample was supplemented with 400 l of 1 M Tris-HCl, pH 8.0, 50 l of chloroform, and 50 l of 0.1% SDS. Reactions were started by the addition of 100 l of PNPP solution (5 mg/ml in 1 M Tris-HCl, pH 8.0), incubated for 2 h at 28°C, and stopped with 100 l of 1 M KH 2 PO 4 ; A 420 was measured after centrifugation.
To determine LacZ activity, samples were supplemented with 50 l of 0.1% SDS, 50 l of chloroform, and 400 l of Z buffer. Reactions were started by the addition of 200 l of ONPG solution, incubated for 2 h at 28°C, and stopped with 500 l of 1 M Na 2 CO 3 ; A 420 was measured after centrifugation.
Immunoblots-The fusion proteins were separated by SDS-PAGE (10% acrylamide) and blotted onto nitrocellulose filters as described (24) . Filters were blocked for 1 h with blocking buffer (10 mM Tris-HCl, pH 7.2, 0.9% NaCl, 0.01% NaN 3 , 1% casein, 1% gelatine), supplemented with anti-PhoA antibodies (dilution 1:2000), and incubated for 2 h at room temperature. Filters were washed five times (10 min each) with TNA (10 mM Tris-HCl, pH 7.2, 0.9% NaCl, 0,01% NaN 3 ) and once with TNA supplemented with 0.05% Nonidet P-40. Anti-rabbit 125 I-IgG was added to a final concentration of 1 g/ml (1 Ci/ml), and the filters were incubated for 2 h at room temperature. Filters were washed six times with TNA (5 min each), three times with TNA supplemented with 0.05% Nonidet P-40, dried, and exposed to x-ray film (2 days).
Construction of Putative Cytoplasmic LacZ and PhoA Fusions to Truncated V2
Receptor Sequences-A schematic depiction of the fusion genes used in this study is shown in Fig. 1 . We have previously constructed the expression plasmid pRCDN2 for the expression of the V2 receptor cDNA in eucaryotic cells (20) . The unique BamHI site of this plasmid was eliminated with a fill-in reaction (data not shown). In order to fuse LacZ, two novel BamHI sites were introduced at nucleotides 284 or 1172 into the V2 receptor cDNA (1) by site-directed mutagenesis, yielding pEUBA71 (Fig. 1a ) or pEUBA367 respectively (Fig. 1b ) (primer at nucleotide 284, 5Ј-GGGGCCACTGGGATCCCATACACGTCTTC-3Ј; primer at nucleotide 1172, 5Ј-CCCTGGCCAAGGATCCTTCATCGT-GAGG-3Ј). The LacZ gene of E. coli was isolated from the transposon TnlacZ as a BamHI fragment (17) and inserted in-frame into the BamHI-cut plasmids described above. In the resulting plasmids pEU71.LacZ (Fig. 1c ) and pEU367.LacZ (Fig. 1e) , LacZ was fused to V2 receptor sequences encoding (a) the N terminus, first transmembrane helix, and first intracellular loop (71 amino acids); and (b) the entire protein except for the four C-terminal residues (367 amino acids), respectively. For the equivalent PhoA fusions, the PhoA-coding region was PCR-amplified from the transposon TnphoA with a 5Ј and a 3Ј primer introducing a BamHI and BglII site, respectively (5Ј primer, 5Ј-GCGTCCTGGACGGATCCTTTCCCGTTTTG-3Ј; 3Ј primer, 5Ј-GCG-TATGCGCCCGAGATCTGCCATTAAG-3Ј). The BamHI/BglII-cut PCR fragment was cloned into BamHI-cleaved pEU71.LacZ to replace LacZ. From the resulting plasmid pEU71.PhoA (Fig. 1f) , PhoA was cloned as a BamHI/XbaI fragment into BamHI/XbaI-cleaved pEU367.LacZ, yielding pEU367.PhoA (Fig. 1h) .
For the expression of the fusion genes in E. coli CC118, we used the vector pTRC99A. The V2 receptor cDNA was PCR-amplified from the original sequence with a 5Ј/3Ј primer pair introducing an NcoI site overlapping the start codon and a BamHI site downstream of the stop codon (5Ј primer, 5Ј-CCCCAGCCCCACCATGGTCATGGCGTCC-3Ј; 3Ј primer, 5Ј-GACACCCAACGGATCCTCACGAGTGAAGTG-3Ј). The NcoI/BamHI-cleaved PCR fragment was cloned into pTRC99A. In the resulting plasmid, pCRVR99A (Fig. 1i) , the NheI/XbaI fragment was replaced by the NheI/XbaI fragments of pEU71.LacZ and pEU367.LacZ, yielding pPRO71.LacZ (Fig. 1j ) and pPRO367.LacZ (Fig. 1l) , respectively. For the equivalent PhoA fusions, the BamHI/XbaI fragment of pEU367.PhoA was used to replace LacZ in BamHI/XbaI-cut pPRO71.LacZ and pPRO367.LacZ. The resulting plasmids were designated pPRO71.PhoA (Fig. 1m ) and pPRO367.PhoA (Fig. 1o) .
Construction of Putative External LacZ and PhoA Fusions-For the construction of putative external fusions, we amplified the original V2 receptor cDNA with a 5Ј primer (5Ј-GGGACCCGCTGCTAGCC-3Ј), overlapping the unique NheI site of the V2 receptor cDNA and a 3Ј primer (5Ј-GACGGCCCCAGGGATCCGCAAAGCAGGCCC-3Ј) introducing a novel BamHI site at nucleotide 662. The NheI/BamHI PCR fragment was cloned into pPRO367.PhoA. In the resulting plasmid, pPRO197.PhoA (Fig. 1n) , PhoA was fused to V2 receptor sequences encoding the four N-terminal transmembrane helices and 17 amino acids of the third extracellular domain (197 amino acids). The equivalent LacZ fusion, pPRO197.LacZ (Fig. 1k) , was constructed by replacing the BamHI/XbaI fragment of plasmid pPRO197.PhoA with the BamH/ XbaI fragment of pPRO71.LacZ. For the construction of the corresponding eucaryotic fusions, the SrfI/XbaI fragments of plasmids pPRO197.PhoA and pPRO197.LacZ were cloned into pEU367.PhoA and pEU367.LacZ. The resulting plasmids were designated pEU197.PhoA (Fig. 1g ) and pEU197.LacZ (Fig. 1d) , respectively.
Construction of a Glycosylation-defective pEU71.PhoA Mutant-On plasmid pRCDN2, the putative acceptor amino acid for N-linked carbohydrates (Asn-22) was replaced by alanine by site-directed mutagenesis as described (20) , using the oligonucleotide 5Ј-CCAGCCTGC-CCAGCGCTAGCAGCCAGGAGAGG-3Ј. The portion of the cDNA carrying the mutation was cloned as an SrfI/NaeI fragment into pEU71.PhoA, replacing the wild-type fragment (resulting plasmid pEU71.PhoA.N22A).
RESULTS

Expression of the Fusion Proteins in E. coli-We have used gene fusions of
PhoA and LacZ to truncated V2 receptor sequences to study the sequence requirements for membrane insertion and correct topology of GPCRs in the inner membrane of E. coli. To this end, we have cloned the V2 receptor cDNA into the vector pTRC99A, allowing the expression of eucaryotic genes under the control of the IPTG-inducible trc promoter. Using site-directed mutagenesis and PCR mutagenesis, PhoA was fused to V2 receptor sequences encoding 1) the N terminus, first transmembrane helix, and first cytoplasmic loop (71 amino acids; PRO71.PhoA); 2) the N terminus and four Nterminal transmembrane helices, including the connecting loops and 18 amino acids of the second extracellular loop (197 amino acids; PRO197.PhoA); and 3) the entire protein except for the four C-terminal residues (367 amino acids; PRO367.PhoA) (Figs. 1 and 2) . The LacZ and PhoA negative E. coli strain CC118 was transformed with the plasmids, and cells expressing the fusion proteins were fractionated into cytoplasm, periplasm, and total membranes (inner and outer membrane). We first determined the localization and orientation of the PhoA hybrids with enzymatic assays (Fig. 3, A and B) . Negligible PhoA activity was found in the membrane fractions of the two clones with the putative cytoplasmic fusions PRO71.PhoA and PRO367.PhoA. High PhoA activity was found only in the membranes of the clone expressing the putative external fusion PRO197.PhoA; little PhoA activity was detected in the periplasm of the same clone. The observed pattern of enzymatic activities is consistent with the assumed topology of the V2 receptor. However, the data did not verify the N terminus and the first transmembrane helix as the minimal signal for membrane insertion and correct orientation because it was not clear whether the fusion protein PRO71.PhoA had reached the membrane. A transport-defective fusion protein located exclusively in the cytoplasm would also be inactive. Western blot analyses of the cell fractions were carried out to clarify this ambiguity. As shown in Fig. 3C , all three intact fusion proteins were present in membrane fractions in substantial amounts. Together with the data for enzymatic activities, these results prove that for the inner membrane of E. coli, the N terminus, first transmembrane helix, and first cytoplasmic loop are sufficient for both membrane targeting/insertion and correct orientation of the V2 receptor. The apparent molecular mass of the short fusion PRO71.PhoA (55 kDa) was found to be identical with its calculated size, whereas fusions PRO197.PhoA and PRO367.PhoA migrated faster than calculated (65 versus 69 kDa and 76 versus 87 kDa, respectively). Since the observed deviations (PRO197.PhoA ϭ 3 kDa; PRO367.PhoA ϭ 9 kDa) were proportional to receptor length, the discrepancies between the apparent and the calculated molecular masses are probably caused by incomplete unfolding of the receptor portions in the presence of SDS. In the periplasm of the clone expressing the translocated fusion protein PRO197.PhoA, an immunoreactive protein band was observed, its molecular mass (48 kDa) corresponding to that of mature PhoA. In addition, three major degradation products (Ն48 kDa) were present in the membrane fractions. These observations could be explained by proteolysis of the membrane-bound fusion protein by periplasmic or outer membrane proteases either in vivo or during the cell fractionation procedure and subsequent release of the PhoA moiety, which is itself resistant to proteolytic degradation. Similar proteolytic processing leading to protease-resistant mature PhoA in the periplasm was observed in previous studies (15, 16) . For fusion PRO197.PhoA, the total amount of protein found in the membranes (i.e. the intact fusion protein and the three degradation products) and in the periplasm (i.e. the released PhoA moiety) correlates well with the PhoA activities found in the periplasm, assuming that all degradation products are enzymatically active. In the clone expressing the fusion PRO71.PhoA, the intact fusion protein was also found in the cytoplasm. These observations suggest that the transport system of E. coli can process only limited amounts of a fusion protein when only the first transmembrane segment of the V2 receptor is present, a problem that can obviously be overcome when additional transmembrane segments are present (fusions PRO197.PhoA and PRO367.PhoA).
To confirm the results, we replaced the PhoA portions of the three hybrids with LacZ, which is active in the cytoplasm, i.e. the complementary sensor to PhoA (plasmids pPRO71.LacZ, pPRO197.LacZ, and pPRO367.LacZ; Figs. 1 and 2 ). E. coli CC118 clones expressing these fusion proteins were fractionated into cytoplasm, membranes, and periplasm, and LacZ activity assays were carried out (Fig. 4, A and B) . The membrane fractions of the clones with the putative cytoplasmic fusions PRO71.LacZ and PRO367.LacZ showed significant and comparable LacZ activity. In contrast, LacZ activity was hardly detectable in membranes of the clone with the putative periplasmic fusion PRO197.LacZ, indicating that the cells had attempted to export the enzyme portion. These results confirmed our data obtained with the PhoA fusions, i.e. that for the inner membrane of E. coli the first 71 amino acids of the V2 receptor are sufficient for both membrane targeting/insertion and correct orientation. In addition, the impaired membrane transport of the fusion PRO71.LacZ was confirmed since the cytoplasmic fraction showed high LacZ activity. In contrast to the corresponding PhoA fusions, the additional transmembrane helices present in fusions PRO197.LacZ and PRO367.LacZ are obviously not sufficient to provide complete membrane targeting since significant LacZ activity was still found in the cytoplasm (see "Discussion").
Expression of the Fusion Proteins in COS.M6 Cells-
The signals for ER membrane-targeting/insertion and topology generation of GPCRs have not previously been studied in eucaryotic cells. We have extended the PhoA gene fusion system with the corresponding LacZ controls to transiently transfected eucaryotic COS.M6 cells. For the construction of the fusion genes, we used the expression plasmid pRCDN2 (20) , which encodes the V2 receptor cDNA under the control of the CMV promoter. The PhoA gene was fused to the same portions of the V2 receptor cDNA as described for the bacterial expression plasmids yielding plasmids pEU71.PhoA, pEU197.PhoA, and pEU367.PhoA (Figs. 1 and 2 ). Although it is clear that PhoA does not interfere with the fused N-terminal protein portions in bacterial cells, it was not clear whether the same holds true for eucaryotic cells. Therefore, we first characterized the longest fusion protein EU367.PhoA functionally to ensure that the PhoA portion did not impair receptor folding and/or receptor transport. Ltk Ϫ mouse fibroblasts were stably transfected with plasmids pRCDN2 (20) pEU367.PhoA encoding the PhoA fusion to the entire V2 receptor except the four C-terminal residues (Fig. 2) . Cell clones expressing similar receptor numbers were selected, and (Table I) for [ 3 H]AVP binding of the receptor without and with PhoA tag receptor were indistinguishable within experimental error (3.0 nM and 1.4 nM, respectively). The ability of both receptors to activate the G s /adenylyl cyclase system was assessed with crude membrane fractions. The EC 50 values for AVP stimulation of adenylyl cyclase via the PhoA-tagged receptor (46.8 nM) was 10-fold higher than the value obtained with the receptor without PhoA moiety (5 nM), which may reflect a slightly impaired G-protein coupling, most presumably due to a steric hindrance caused by the relatively large PhoA moiety. These results show that the fusion protein is expressed on the cell surface and is functional, indicating that receptor folding is not disturbed.
To assess membrane insertion and orientation of the PhoA fusion proteins, COS.M6 cells were transiently transfected with the corresponding expression plasmids. Cells were fractionated into cytoplasmic and membrane fractions, and PhoA activity assays and SDS-PAGE/immunoblot analyses were carried out. No increase in phosphatase activity was detected, suggesting that bacterial PhoA was not functional in eucaryotic cells (data not shown). Western blot analysis revealed that specifically stained proteins were present exclusively in the membrane fractions (Fig. 5, A and B) . For the cytoplasmic fusions EU71.PhoA and EU367.PhoA, two major bands were observed (55 and 68 kDa, and 76 and 97 kDa, respectively). For the external fusion EU197.PhoA, one broad band migrating at 69 kDa was detected. The lower bands of fusions EU71.PhoA and EU367.PhoA (55 and 76 kDa, respectively) obviously represent the unmodified forms of the fusion proteins, since expression in E. coli revealed identical molecular masses (see above). The broad upper bands (68 and 97 kDa, respectively) represent glycosylated forms (see below). For the external fusion EU197.PhoA, the broad band (69 kDa) may be composed of the unmodified form (65 kDa; see expression in E. coli) and incompletely glycosylated forms. The complex glycosylation of EU197.PhoA may be depressed by the luminal PhoA portion of this fusion protein.
Since glycosylation requires translocation into the ER lumen, this modification can be used as a topological marker instead of the nonfunctional enzyme portion. Therefore, we eliminated the putative N-glycosylation site of the fusion EU71.PhoA (N22) by site-directed mutagenesis (mutant EU71.PhoA.N22A). In the membranes of COS.M6 cells transfected with pEU71.PhoA.N22A, the upper band observed in the wild type construct (68 kDa) was not present (Fig. 5, A and C) . The same was observed for the wild-type fusion after peptide N-glycosidase F treatment. But neither the mutation nor the peptide N-glycosidase F treatment changed the apparent molecular mass to that of the unmodified form (55 kDa) found in eucaryotic cells and in E. coli. Instead, a novel form appeared, with an apparent molecular mass of 61 kDa. This suggests that additional posttranslational modifications occur in the N-terminal part of the V2 receptor (e.g. O-glycosylation or phosphorylation). Similar results were obtained for fusion EU367.PhoA and its N-glycosylation-deficient mutant (data not shown). In summary, our data prove that the fusion protein EU71.PhoA is N-glycosylated; hence, the N terminus must have been translocated into the ER lumen. Thus, the N terminus, first transmembrane segment, and first cytoplasmic loop of the V2 receptor do indeed provide sufficient information for both membrane targeting/insertion and correct topology in the ER membrane of eucaryotic cells.
To verify these data, we constructed the complementary fusion genes encoding LacZ instead of PhoA (plasmids pEU71.LacZ, pEU197.LacZ, and pEU367.LacZ; Figs. 1 and 2) . Transiently transfected COS.M6 cells were fractionated into cytoplasm and membranes, and LacZ activity assays were performed. LacZ activity was high in the membranes of cells expressing the putative cytoplasmic fusions EU71.LacZ and EU367.LacZ (Fig. 6, A and B) . Activity was barely detectable in the membranes with the putative external fusion EU197.LacZ, indicating that the cells had attempted to export LacZ. Simi- larly to the PhoA fusions, none of the LacZ hybrids were detectable in the cytoplasm. The extracellular activity, which was low in all cases, is most likely accounted for by cell damage. The data obtained with LacZ fusions are entirely consistent with those obtained with PhoA fusions and provide further evidence that the N-terminal 71 amino acids of the V2 receptor are sufficient for ER membrane targeting/insertion and correct topology in eucaryotic cells. In addition we show for the first time that LacZ fusions are well suited for the localization of the cytoplasmic domains of a membrane protein not only in procaryotic but also in eucaryotic cells.
DISCUSSION
GPCRs possess seven transmembrane segments, an extracellular N terminus, and an intracellular C terminus. The mechanisms of membrane targeting/insertion and topology generation of these proteins are for the most part unknown and have previously been studied only in E. coli (14) . In this report we demonstrate with PhoA and LacZ fusion proteins that a truncated V2 receptor consisting of the N terminus, the first transmembrane segment, and first cytoplasmic loop provides sufficient information for both membrane targeting/insertion and correct orientation. We show that this is valid not only for the inner membrane of E. coli but also for the ER membrane of COS.M6 cells. We also demonstrate the superior efficiency of the eucaryotic transport system over the procaryotic transport system regarding GPCR processing.
The fact that the first 71 amino acids of the V2 receptor confer sufficient information for membrane targeting supports recent data obtained for the G-protein-coupled ␤ 2 -adrenergic receptor, where PhoA fusions to the first cytoplasmic loop were also inserted into the inner membrane of E. coli (14) . However, the same authors showed that the orientation of this fusion protein was inverted and that a fragment comprising the N terminus, the three N-terminal helices, and part of the second cytoplasmic loop was necessary to establish the correct topology. For the V2 receptor, this is clearly not the case, since both PhoA and LacZ fusions to the first intracellular domain were inserted in the predicted orientation in E. coli and in COS.M6 cells. The conflicting results in E. coli could arise from the differing numbers of positively charged amino acids in the first cytoplasmic domains of the ␤ 2 -adrenergic receptor and the V2 receptor. According to the "positive inside rule" of von Heijne, membrane proteins are oriented such that the more positively charged loops point toward the cytoplasm (6 -9). It was recently shown for the inner membrane of E. coli that the positive inside rule can be explained by the electrochemical potential, ⌬ H ϩ, which is established by the components of the respiratory chain and favors the location of positive residues at the cytoplasmic side (25) . Whereas the net charge difference between the first cytoplasmic loop and the N terminus is highly positive for the V2 receptor (⌬(C-N) ϭ ϩ4; Fig. 2) , it is only ϩ1 for the ␤ 2 -adrenergic receptor. In the case of the V2 receptor, this excess of positively charged residues may be sufficient to establish the correct topology. In the case of the ␤ 2 -adrenergic receptor, correct orientation in the inner membrane of E. coli may require the second cytoplasmic loop, which has a higher positive charge, as discussed previously (14) . At the ER membrane of eucaryotic cells, there is no proton gradient. In this context, it would be of great interest to determine whether the data for the ␤ 2 -adrenergic receptor obtained in E. coli can be extended to the eucaryotic transport system or whether they are restricted to the bacterial expression system. If one assumes that the ␤ 2 -adrenergic receptor fragment would be oriented correctly in the ER membrane, other mechanisms than the positive inside rule must contribute toward establishing correct topology in eucaryotic cells.
In E. coli, fusion PRO71.PhoA and the three LacZ fusions were found in substantial amounts in the cytoplasm. This cytoplasmic protein pool was disadvantageous especially for the interpretation of LacZ data: a "false positive" LacZ phenotype is observed for the external fusions when only whole cell activity is monitored. This problem was resolved by determining cytoplasmic and membrane-bound activities separately. The cytoplasmic protein pools may result from specific properties of the E. coli transport system. In E. coli, protein synthesis and inner membrane insertion are not tightly coupled, giving rise to a more or less extensive posttranslational transport with cytoplasmic intermediates (9, 26) . Chaperones such as SecB are necessary to maintain the cytoplasmic precursors in a transport-competent state. The impaired transport of the fusion proteins into the inner membrane may be caused by a limited number of chaperones able to process GPCR-like proteins, leading to the accumulation of cytoplasmic intermediates.
We have extended for the first time the LacZ/PhoA fusion protein system to eucaryotic cells. Whereas both types of fusions are efficiently targeted to the ER membrane, only the LacZ fusions are enzymatically active. In contrast to E. coli, both PhoA and LacZ hybrids were located exclusively in the membrane fractions of COS.M6 cells. Therefore, the authentic eucaryotic transport system seems to function very efficiently when compared to that of E. coli. In eucaryotic cells, membrane proteins are targeted to the ER membrane with the help of the signal recognition particle complex and a docking protein and are inserted cotranslationally by a transport machinery, which appears to be tightly linked to the translating ribosome (12) . The cotranslational insertion in eucaryotic cells seems to be of additional advantage for the efficiency of the LacZ system. Since translation and membrane insertion are tightly coupled, LacZ folding in the cytoplasm should be prevented. Therefore, false positive LacZ fusions arising from posttranslational folding in the cytoplasm as discussed above for E. coli should not occur. This assumption was confirmed for the LacZ fusions investigated in the present study.
Whereas PhoA activity of the fusion proteins was not detectable, the LacZ system succeeded. For eucaryotic cells, only methods for studying external domains of membrane proteins are well established (e.g. proteolysis, monoclonal antibodies, and artificial glycosylation sites). LacZ fusions described in the present paper fill a gap by allowing the localization of cytoplasmic domains by the use of an enzymatic assay.
